Royalty Report: Drugs, Food, Nutraceutical – Collection: 7635

$150.00

Curated Royalty Rate Report
Category: Technology Licenses, Created On: 2022-04-28, Record Count: 10

Description

This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 10

Primary Industries

  • Drugs
  • Food
  • Nutraceutical
  • Disease
  • Therapeutic

IPSCIO Report Record List

Below you will find the records curated into this collection.  This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs.  The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms.  For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report

IPSCIO Record ID: 7635

License Grant
Israelis Licensor hereby grants to Israelis Licensee the exclusive right and license under the Patent Rights to make, have made, use and sell Licensed Products in the Territory, for the Field of Use.
License Property
Licensor is the owner of certain 'Patent Rights' (as defined in Article 1) relating to improved oral delivery of lipophilic substances.
Field of Use
'Field of Use' shall mean the field of Nutraceuticals, specifically in the following categories formulation of food and dietary supplements, food additives, nutritional ingredients, natural ingredients, food industry, food ingredients, food and functional food applications, nutritional beverages, vitamins, minerals, herbals, herbal supplements, health nutrients, phytonutraceuticals, cosmetics, cosmoceuticals (excluding any and all existing or future topical pharmaceutical applications and or uses in the cosmetic and/or cosmoceuticals fields) and any new applications or uses developed or arising in the field of Nutraceuticals.

IPSCIO Record ID: 968

License Grant
The Company's subsidiary modified a License Agreement a company controlled by Company's Chairman and Chief Executive Officer.  The License Agreement, originally entered into in May 1997, licenses the Company's patent rights for the oral delivery of lipophilic substances.
Field of Use
The rights granted apply in the limited field of nutraceuticals, which include food and dietary supplements, food additives, vitamins and herbs.

IPSCIO Record ID: 7233

License Grant
The Canadian Licensor grants the Canadian Licensee, a subsidiary, an exclusive, non-transferable license for the term and in the worldwide territory to use the Licensed Intellectual Property solely within the Licensed Field and where it relates to the development and commercialization of Licensed Products.
License Property
Licensed Field means the development, distribution and sale of Over-the-Counter Products, Prescription Medical Food Products and Prescription Drug Products for used in the human cardiovascular field and containing a concentration of phospholipids extracted from Krill.  
Krill are small crustaceans of the order Euphausiacea, and are found in all the world's oceans.

Nutraceutical Products means any dietary supplement or functional food that has proven health and medical benefits.  Dietary Supplement means a product isolated or purified from foods that is generally sold in medicinal forms not usually associated with food; a dietary supplement is demonstrated to have a physiological benefit to maintain healthy physiological systems.  Functional Food is similar in appearance to, or may be conventional food, is consumed as part of a usual diet, and is demonstrated to have physiological benefits to maintain healthy physiological systems beyond basic nutritional functions.

Nutrigenomic Products means Nutraceuticals designed to interact with specific genes to reduce the risk of common chronic diseases by altering the expression of genes and the structure of an individual’s genome.

Field of Use
Licensed Field means the development, distribution and sale of Over-the-Counter Products, Prescription Medical Food Products and Prescription Drug Products for used in the human cardiovascular field and containing a concentration of phospholipids extracted from Krill.  
Krill are small crustaceans of the order Euphausiacea, and are found in all the world's oceans.

The Licensee is a Canadian-based biopharmaceutical company dedicated in the research, development and commercialization of innovative proprietary active pharmaceutical ingredients for the management of cardiometabolic disorders, from prevention to treatment, bridging the treatment gap in lipid management.

IPSCIO Record ID: 27285

License Grant
The Company granted a five-year license, an amendment to the license above, in the area of functional foods to use existing technology and future technology improvements in the development, formulation, manufacture, marketing, distribution and sale of kefir-based products, as defined in the granted license.
Field of Use
The rights granted apply to the area of functional foods.

IPSCIO Record ID: 7242

License Grant
Chinese Licensor has entered into an Exclusive Licensing Agreements with Licensee.

Chinese Licensor have

(1) special relationships with leading Chinese medical and nutrition institutions,
(2) special expertise and know how in the use of natural products for the treatment and prevention of disease and maintenance of health,
(3) relationships with Chinese clinicians and researchers and
(4) expertise and know how in the licensing, research and development of products.

License Property
Products as so termed in this Agreement shall be defined as non-prescription drugs and medicines, foods, food supplements, nutritional supplements, extracts from naturally derived sources and the know-how, intellectual property and technology for developing future products derived from natural sources that can be used in the prevention and treatment of disease and maintenance of health and well-being.

IPSCIO Record ID: 26477

License Grant
The Licensor is willing to grant the Licensee a right of first refusal to acquire its nutritionally dense ingredients and to grant the Licensee an exclusive arrangement in the entire human market.
License Property
The Licensor is a producer of nutritionally dense ingredients and related products
Field of Use
Licensee has been formed to engage in the distribution and sale of nutraceutical products involving nutritionally dense ingredients, and desires to obtain a supply of nutritionally dense ingredients.

IPSCIO Record ID: 4401

License Grant
This licensing agreement allows Licensee the non-exclusive use of Licensor's trade secrets regarding its proprietary Agronifierâ„¢ processes, materials, equipment, software, whether in print, electronic or other medium, services, software, and hardware for the treatment specifically of foods, supplements and liquids and may not be used for any other use.
License Property
The Trade Secrets are relating to Licensor proprietary AgronifierTM processes, materials, equipment, software, and hardware (the Agronifier Technology), limited to the treatment of foods, supplements and liquids.

Agronifier is a device for generating electromagnetic and acoustic waves used to modify the taste of food, water, wine, and other beverages. Electromagnetic field and sound producing equipment that is used to modify the taste of food, water, wine, and other beverages

It was later discovered that its acoustic and electromagnetic waves also enhanced the effects of the nutraceuticals and functional beverages while improving the flavor of food and drinks.

Field of Use
The Licensee has the right to use the Agronifier Technology to treat foods and beverages, as well as food supplements and the Licensee's nutraceutical products.

As with the product License Agreement, the Licensee intends to both sublicense these rights  and to use the Agronifier Technology, either directly or through a subsidiary entity, to treat foods, wine, and to build products incorporating the Agronifier Technology for resale.

IPSCIO Record ID: 7003

License Grant
The Licensor will grant to Licensee a perpetual, exclusive, worldwide license under patents and associated know-how and other intellectual property rights to develop, manufacture and commercialize probiotics for use as dietary supplements for human consumption or human use over-the-counter without a prescription or otherwise in the vitamins, minerals and supplements market (including foods or beverages marketed as supplements).

The Licensor hereby grants to Licensee, and Licensee hereby accepts, an exclusive, worldwide, license under the Licensed Patents to research, develop, improve, produce, manufacture, have manufactured, market, promote, offer to sell, sell, use, import, distribute and commercialize Probiotics and Products and otherwise exploit the Licensed Patents, in each case, for use in the Licensed Field of Use (the Patent License).

The Licensor grants to Licensee, an exclusive, worldwide License to use the Licensed Trademarks on any Product for use in the Field of Use including the use of BC30.

The Licensor grants an exclusive, worldwide License under the Licensed Copyrights.

License Property
The Licensor transferred certain inventory, receivables and intellectual property and certain liabilities relating to probiotic brands Sustenex and Digestive Advantage.
Field of Use
The rights granted apply for the use as dietary supplements for human consumption or human use over-the-counter without a prescription or otherwise in the vitamins, minerals and supplements market.

In connection Asset Purchase, Licensee wishes to obtain an exclusive, Worldwide License to certain Intellectual Property Rights including all Patents Controlled by the Licensor including all Patents that claim or otherwise cover, any Probiotic or Product, or the research, development, manufacture, use or commercialization thereof.

IPSCIO Record ID: 26196

License Grant
The Licensor, an individual, granted the Licensee an exclusive worldwide License to develop, manufacture and sell certain carbohydrate complexes of boron nutraceutical compounds.  The Licensor originally filed a provisional patent application covering the compounds, and subsequently filed a further United States patent application. Pursuant to the Agreement, the Licensee is responsible for all costs and expenses in connection with obtaining patent protection.
License Property
Patent relates to certain carbohydrate complexes of boron nutraceutical compounds.

US Patent Number 5,962,049 Boron Carbohydrate Complexes and Uses Thereof was issued October 5, 1999.

Field of Use
The field of the invention is dietary boron.

IPSCIO Record ID: 1874

License Grant
Licensor hereby grants and Licensee hereby accepts an Exclusive right and license to make, have made, use, distribute, license, sell, have sold or otherwise dispose of the Product, and to use the Technology to undertake such activities with respect to the Product in the Territory during the Term of the Agreement.
License Property
Licensor has developed a medical food product, known as NiteBite.

'Patent Rights' refers to Licensor's rights arising from Provisional U.S. Patent Application 08/815,595.

Field of Use
'Product' shall mean the NiteBite Timed-release Glucose Bar (TM), any enhanced or modified versions thereof that Licensor develops during the Term of this Agreement, and all oral delivery formats (e.g., nutrition bars, beverages, etc.) which provide the benefits of the timed-release glucose formulation in NiteBite for the management of blood glucose in people with diabetes that are developed, manufactured, used or sold by Licensee during the Term of this Agreement.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.